A JAMA trial of 3,959 adults with septic shock found that starting vasopressin earlier did not improve survival or recovery compared with waiting.
Adding Vasopressin Earlier Did Not Improve Septic Shock Survival in 3,959-Patient Trial at 13 Utah and Idaho Hospitals
by | Oct 15, 2026 | Uncategorized | 0 comments

Recent Comments